Anthropic CEO talks drug discovery, Medicare proposes steep 340B drug payment cuts, and more biotech news

Novartis is pushing deeper into antibody-drug conjugate development, paying $1.1 billion upfront to buy Myricx Bio

Anthropic CEO talks drug discovery, Medicare proposes steep 340B drug payment cuts, and more biotech news